| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 免疫系统用药(元) | 59,600,300.22 | 149,341,780.05 | 75,676,074.80 |
| 神经系统用药(元) | 49,542,395.20 | 41,915,123.96 | 19,905,253.56 |
| 心脑血管用药(元) | 84,782,660.85 | 220,103,668.96 | 116,755,907.69 |
| 其他(元) | 2,875,817.33 | 5,121,216.66 | 2,499,682.73 |
| 营业成本(元) | |||
| 免疫系统用药(元) | 19,532,168.49 | 57,404,327.20 | 29,182,470.67 |
| 神经系统用药(元) | 26,416,489.96 | 21,643,299.78 | 11,780,890.03 |
| 心脑血管用药(元) | 20,721,799.96 | 55,119,860.83 | 30,505,618.08 |
| 其他(元) | 2,640,284.34 | 6,263,671.98 | 2,533,076.03 |
| 毛利(元) | |||
| 免疫系统用药(元) | 40,068,131.73 | 91,937,452.85 | 46,493,604.13 |
| 神经系统用药(元) | 23,125,905.24 | 20,271,824.18 | 8,124,363.53 |
| 心脑血管用药(元) | 64,060,860.89 | 164,983,808.13 | 86,250,289.61 |
| 其他(元) | 235,532.99 | -1,142,455.32 | -33,393.30 |
| 毛利率(%) | |||
| 免疫系统用药(%) | 67.23 | 61.56 | 61.44 |
| 神经系统用药(%) | 46.68 | 48.36 | 40.82 |
| 心脑血管用药(%) | 75.56 | 74.96 | 73.87 |
| 其他(%) | 8.19 | -22.31 | -1.34 |
| 收入构成(%) | |||
| 免疫系统用药(%) | 30.28 | 35.86 | 35.22 |
| 神经系统用药(%) | 25.17 | 10.06 | 9.27 |
| 心脑血管用药(%) | 43.08 | 52.85 | 54.35 |
| 其他(%) | 1.46 | 1.23 | 1.16 |
| 毛利构成(%) | |||
| 免疫系统用药(%) | 31.43 | 33.30 | 33.01 |
| 神经系统用药(%) | 18.14 | 7.34 | 5.77 |
| 心脑血管用药(%) | 50.25 | 59.77 | 61.24 |
| 其他(%) | 0.18 | -0.41 | -0.02 |